125 related articles for article (PubMed ID: 15746058)
21. Expression of the hMLH1 gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer.
Ide T; Kitajima Y; Ohtaka K; Mitsuno M; Nakafusa Y; Miyazaki K
Oncol Rep; 2008 Jun; 19(6):1571-6. PubMed ID: 18497967
[TBL] [Abstract][Full Text] [Related]
22. Mismatch repair gene promoter methylation and expression in hydatidiform moles.
Chen H; Ye D; Xie X; Lu W; Zhu C; Chen X
Arch Gynecol Obstet; 2005 Jun; 272(1):35-9. PubMed ID: 15338238
[TBL] [Abstract][Full Text] [Related]
23. Promoter methylation of the hMLH1 gene and protein expression of human mutL homolog 1 and human mutS homolog 2 in resected esophageal squamous cell carcinoma.
Tzao C; Hsu HS; Sun GH; Lai HL; Wang YC; Tung HJ; Yu CP; Cheng YL; Lee SC
J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1371. PubMed ID: 16256791
[TBL] [Abstract][Full Text] [Related]
24. Mutually exclusive promoter hypermethylation patterns of hMLH1 and O6-methylguanine DNA methyltransferase in colorectal cancer.
Fox EJ; Leahy DT; Geraghty R; Mulcahy HE; Fennelly D; Hyland JM; O'Donoghue DP; Sheahan K
J Mol Diagn; 2006 Feb; 8(1):68-75. PubMed ID: 16436636
[TBL] [Abstract][Full Text] [Related]
25. Promoter methylation and expression of DNA repair genes hMLH1 and MGMT in acute myeloid leukemia.
Lenz G; Hutter G; Hiddemann W; Dreyling M
Ann Hematol; 2004 Oct; 83(10):628-33. PubMed ID: 15309527
[TBL] [Abstract][Full Text] [Related]
26. Roles of mismatch repair proteins hMSH2 and hMLH1 in the development of sporadic breast cancer.
Murata H; Khattar NH; Gu L; Li GM
Cancer Lett; 2005 Jun; 223(1):143-50. PubMed ID: 15890247
[TBL] [Abstract][Full Text] [Related]
27. Promoter hypermethylation is a major event of hMLH1 gene inactivation in liver fluke related cholangiocarcinoma.
Limpaiboon T; Khaenam P; Chinnasri P; Soonklang M; Jearanaikoon P; Sripa B; Pairojkul C; Bhudhisawasdi V
Cancer Lett; 2005 Jan; 217(2):213-9. PubMed ID: 15617839
[TBL] [Abstract][Full Text] [Related]
28. Microsatellite instability in gastric cancer is closely associated with hMLH1 hypermethylation at the proximal region of the promoter.
Ishiguro K; Kawakami K; Maeda K; Ishida Y; Omura K; Watanabe G
Int J Mol Med; 2003 Oct; 12(4):603-8. PubMed ID: 12964042
[TBL] [Abstract][Full Text] [Related]
29. hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis.
Esteller M; Catasus L; Matias-Guiu X; Mutter GL; Prat J; Baylin SB; Herman JG
Am J Pathol; 1999 Nov; 155(5):1767-72. PubMed ID: 10550333
[TBL] [Abstract][Full Text] [Related]
30. Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas.
Koinuma K; Shitoh K; Miyakura Y; Furukawa T; Yamashita Y; Ota J; Ohki R; Choi YL; Wada T; Konishi F; Nagai H; Mano H
Int J Cancer; 2004 Jan; 108(2):237-42. PubMed ID: 14639609
[TBL] [Abstract][Full Text] [Related]
31. DNA methylation of hMLH1 correlates with the clinical response to cisplatin after a surgical resection in Non-small cell lung cancer.
Wu F; Lu M; Qu L; Li DQ; Hu CH
Int J Clin Exp Pathol; 2015; 8(5):5457-63. PubMed ID: 26191250
[TBL] [Abstract][Full Text] [Related]
32. Genetic analysis of hMLH1 in transitional cell carcinoma of the urinary tract: promoter methylation or mutation.
Furihata M; Takeuchi T; Ohtsuki Y; Terao N; Kuwahara M; Shuin T
J Urol; 2001 May; 165(5):1760-4. PubMed ID: 11342971
[TBL] [Abstract][Full Text] [Related]
33. CpG methylation of MGMT and hMLH1 promoter in hepatocellular carcinoma associated with hepatitis viral infection.
Matsukura S; Soejima H; Nakagawachi T; Yakushiji H; Ogawa A; Fukuhara M; Miyazaki K; Nakabeppu Y; Sekiguchi M; Mukai T
Br J Cancer; 2003 Feb; 88(4):521-9. PubMed ID: 12592365
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis of promoter methylation and altered expression of hMLH1 in gastric cancer cell lines with microsatellite instability.
Kang YH; Bae SI; Kim WH
J Cancer Res Clin Oncol; 2002 Mar; 128(3):119-24. PubMed ID: 11935297
[TBL] [Abstract][Full Text] [Related]
35. Clinical implications of mismatched repair gene promoter methylation in pancreatic cancer.
Li M; Zhao ZW
Med Oncol; 2012 Jun; 29(2):970-6. PubMed ID: 21660619
[TBL] [Abstract][Full Text] [Related]
36. Promoter hypermethylation and inactivation of hMLH1, a DNA mismatch repair gene, in head and neck squamous cell carcinoma.
Liu K; Zuo C; Luo QK; Suen JY; Hanna E; Fan CY
Diagn Mol Pathol; 2003 Mar; 12(1):50-6. PubMed ID: 12605036
[TBL] [Abstract][Full Text] [Related]
37. Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines.
Arnold CN; Goel A; Boland CR
Int J Cancer; 2003 Aug; 106(1):66-73. PubMed ID: 12794758
[TBL] [Abstract][Full Text] [Related]
38. Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.
Geisler JP; Goodheart MJ; Sood AK; Holmes RJ; Hatterman-Zogg MA; Buller RE
Cancer; 2003 Nov; 98(10):2199-206. PubMed ID: 14601090
[TBL] [Abstract][Full Text] [Related]
39. Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression.
Deng G; Chen A; Hong J; Chae HS; Kim YS
Cancer Res; 1999 May; 59(9):2029-33. PubMed ID: 10232580
[TBL] [Abstract][Full Text] [Related]
40. Defective mismatch repair and the development of recurrent endometrial carcinoma.
Pijnenborg JM; Dam-de Veen GC; de Haan J; van Engeland M; Groothuis PG
Gynecol Oncol; 2004 Aug; 94(2):550-9. PubMed ID: 15297202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
